ID22746A - Senyawa-senyawa baru - Google Patents

Senyawa-senyawa baru

Info

Publication number: ID22746A
Authority: ID; Indonesia
Prior art keywords: pct; date; new compounds; sec; pub
Prior art date: 1997-04-15

Application number

IDW991207A

Other languages

English (en)

Inventor

David Cheshire

Martin Cooper

David Donald

Philip Thorne

Original Assignee

Astra Pharma Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-15

Filing date

1998-04-07

Publication date

1999-12-09

1998-04-07 Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod

1999-12-09 Publication of ID22746A publication Critical patent/ID22746A/id

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Epidemiology (AREA)
Virology (AREA)
Pulmonology (AREA)
Transplantation (AREA)
Physical Education & Sports Medicine (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)

IDW991207A 1997-04-15 1998-04-07 Senyawa-senyawa baru ID22746A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9701398A SE9701398D0 (sv)	1997-04-15	1997-04-15	Novel compounds

Publications (1)

Publication Number	Publication Date
ID22746A true ID22746A (id)	1999-12-09

Family

ID=20406576

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW991207A ID22746A (id)	1997-04-15	1998-04-07	Senyawa-senyawa baru

Country Status (21)

Country	Link
US (1)	US6028074A (id)
EP (1)	EP0975636B1 (id)
JP (1)	JP2001520645A (id)
KR (1)	KR20010006350A (id)
CN (1)	CN1259951A (id)
AT (1)	ATE245648T1 (id)
AU (1)	AU733066B2 (id)
BR (1)	BR9808540A (id)
CA (1)	CA2286078A1 (id)
DE (1)	DE69816608T2 (id)
EE (1)	EE9900465A (id)
HU (1)	HUP0002104A3 (id)
ID (1)	ID22746A (id)
IL (1)	IL132153A0 (id)
IS (1)	IS5198A (id)
NO (1)	NO995006D0 (id)
PL (1)	PL336230A1 (id)
SE (1)	SE9701398D0 (id)
SK (1)	SK135699A3 (id)
TR (1)	TR199902538T2 (id)
WO (1)	WO1998046606A1 (id)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9801399D0 (sv)	1998-04-21	1998-04-21	Astra Pharma Prod	Method and apparatus for filling containers
GC0000177A (en) *	1998-12-17	2006-03-29	Smithkline Beecham	Thrombopoietin mimetics
CY2010012I2 (el)	2000-05-25	2020-05-29	Novartis Ag	Μιμητικα θρομβοποιητινης
JP2004527541A (ja)	2001-03-01	2004-09-09	スミスクライン・ビーチャム・コーポレイション	トロンボポエチン模倣物
IL160307A0 (en)	2001-08-31	2004-07-25	Univ Rockefeller	Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
MY142390A (en)	2002-05-22	2010-11-30	Glaxosmithkline Llc	3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine)
TW200526638A (en)	2003-10-22	2005-08-16	Smithkline Beecham Corp	2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline
US9226885B2 (en) *	2005-05-24	2016-01-05	Allium Vitalis Incorporated	Personal care and medicinal products incorporating bound organosulfur groups
AU2006255028B2 (en)	2005-06-06	2012-04-19	Intra-Cellular Therapies, Inc.	Organic compounds
KR20090042227A (ko) *	2006-06-06	2009-04-29	인트라-셀룰라 써래피스, 인코퍼레이티드.	유기 화합물
WO2008063505A1 (en)	2006-11-13	2008-05-29	Intra-Cellular Therapies, Inc.	Organic compounds
WO2008070095A1 (en)	2006-12-05	2008-06-12	Intra-Cellular Therapies, Inc.	Novel uses
ECSP077628A (es)	2007-05-03	2008-12-30	Smithkline Beechman Corp	Nueva composición farmacéutica
EP2240028B1 (en) *	2007-12-06	2016-07-20	Intra-Cellular Therapies, Inc.	Pyrazolopyrimidine-4,6-dione derivatives and their use as pharmaceutical
KR20120012831A (ko)	2007-12-06	2012-02-10	인트라-셀룰라 써래피스, 인코퍼레이티드.	유기 화합물
EP2367430B1 (en) *	2008-12-06	2014-08-13	Intra-Cellular Therapies, Inc.	Organic compounds
EP2367431B1 (en)	2008-12-06	2015-08-05	Intra-Cellular Therapies, Inc.	Organic compounds
KR20110103949A (ko)	2008-12-06	2011-09-21	인트라-셀룰라 써래피스, 인코퍼레이티드.	유기 화합물
JP5778582B2 (ja)	2008-12-06	2015-09-16	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	有機化合物
BRPI0922809A2 (pt)	2008-12-06	2018-05-29	Intracellular Therapies Inc	compostos orgânicos
MA32942B1 (fr)	2008-12-06	2012-01-02	Intra Cellular Therapies Inc	Composes organiques
WO2010098839A1 (en)	2009-02-25	2010-09-02	Intra-Cellular Therapies, Inc.	Pde 1 inhibitors for ophthalmic disorders
EP2411395B1 (en)	2009-03-23	2013-05-29	Glenmark Pharmaceuticals S.A.	Furopyrimidinedione derivatives as trpa1 modulators
SI2411393T1 (sl) *	2009-03-23	2014-03-31	Glenmark Pharmaceuticals S.A.	Kondenzirani pirimidin-dionski derivati kot TRPA 1 modulatorji
US8623880B2 (en)	2009-03-23	2014-01-07	Glenmark Pharmaceuticals S.A.	Fused pyrimidine-dione derivatives as TRPA1 modulators
WO2010109328A1 (en)	2009-03-23	2010-09-30	Glenmark Pharmaceuticals, S.A.	Isothiazolo-pyrimidinedione derivatives as trpa1 modulators
JP2012526810A (ja)	2009-05-13	2012-11-01	イントラ−セルラー・セラピーズ・インコーポレイテッド	有機化合物
SG176088A1 (en)	2009-05-29	2011-12-29	Glaxosmithkline Llc	Methods of administration of thrombopoietin agonist compounds
JP6166534B2 (ja)	2009-08-05	2017-07-19	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	新規調節タンパク質および阻害剤
WO2011153135A1 (en)	2010-05-31	2011-12-08	Intra-Cellular Therapies, Inc.	Organic compounds
TW201206937A (en)	2010-05-31	2012-02-16	Intra Cellular Therapies Inc	Organic compounds
EP2576551A4 (en)	2010-05-31	2014-04-16	Intra Cellular Therapies Inc	ORGANIC CONNECTIONS
WO2011153136A1 (en)	2010-05-31	2011-12-08	Intra-Cellular Therapies, Inc.	Organic compounds
JP6051210B2 (ja)	2011-06-10	2016-12-27	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	有機化合物
SG11201408093PA (en)	2012-06-08	2015-01-29	Glenmark Pharmaceuticals Sa	Amides of 2-amino-4-arylthiazole compounds and their salts
US9801882B2 (en)	2013-02-17	2017-10-31	Intra-Cellular Therapies, Inc.	Phosphodiesterase-1 inhibitors and their use in treatment of cardiovascular diseases
EP2968338B1 (en)	2013-03-15	2019-01-09	Intra-Cellular Therapies, Inc.	Pde1 inhibitors for use in the treatment and/or prevention of cns injuries, and pns diseases, disorders or injuries
KR102240326B1 (ko)	2013-03-15	2021-04-13	인트라-셀룰라 써래피스, 인코퍼레이티드.	유기 화합물
JP6696904B2 (ja)	2014-01-08	2020-05-20	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	製剤および医薬組成物
EP3157926B1 (en)	2014-06-20	2019-05-15	Intra-Cellular Therapies, Inc.	Organic compounds
US9546175B2 (en)	2014-08-07	2017-01-17	Intra-Cellular Therapies, Inc.	Organic compounds
US10131671B2 (en)	2014-08-07	2018-11-20	Intra-Cellular Therapies, Inc.	Organic compounds
US10285992B2 (en)	2014-08-07	2019-05-14	Intra-Cellular Therapies, Inc.	Combinations of PDE1 inhibitors and NEP inhibitors and associated methods
CA2961212C (en)	2014-09-17	2024-02-06	Intra-Cellular Therapies, Inc.	Compounds and methods
HK1244427A1 (zh)	2014-12-06	2018-08-10	Intra-Cellular Therapies, Inc.	有机化合物
CA2969594A1 (en)	2014-12-06	2016-06-09	Intra-Cellular Therapies, Inc.	Pde2 inhibiting organic compounds
US10682354B2 (en)	2016-03-28	2020-06-16	Intra-Cellular Therapies, Inc.	Compositions and methods
CN109311886B (zh) *	2016-06-23	2021-11-09	豪夫迈·罗氏有限公司	[1,2,3]三唑并[4,5-d]嘧啶衍生物
JP7134168B6 (ja)	2016-09-12	2024-02-02	イントラ－セルラー・セラピーズ・インコーポレイテッド	新規使用
JP7401442B2 (ja)	2018-01-31	2023-12-19	イントラ－セルラー・セラピーズ・インコーポレイテッド	新規使用
EP4413980A3 (en)	2019-09-03	2024-10-30	Intra-Cellular Therapies, Inc.	Novel compounds
US12364695B2 (en)	2020-06-02	2025-07-22	Intra-Cellular Therapies, Inc.	Methods of treating inflammatory disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0077372A1 (de) *	1981-04-22	1983-04-27	Byk Gulden Lomberg Chemische Fabrik GmbH	NEUE PYRAZOLO(3,4-d)PYRIMIDINE, VERFAHREN ZU DEREN HERSTELLUNG UND SIE ENTHALTENDE ARZNEIMITTEL
US4603203A (en) *	1983-12-14	1986-07-29	Takeda Chemical Industries, Ltd.	3-aminopyrazolo[3,4-d]pyrimidine derivatives and production thereof
EP0237289A3 (en) *	1986-03-14	1988-07-27	Takeda Chemical Industries, Ltd.	Pyrazolo [3,4-d] pyrimidine derivatives, their production and use
TW370529B (en) *	1992-12-17	1999-09-21	Pfizer	Pyrazolopyrimidines
CZ284157B6 (cs) *	1992-12-17	1998-08-12	Pfizer Inc.	Pyrazolové a pyrazolopyrimidinové sloučeniny jako takové a pro léčbu chorob a farmaceutické prostředky na jejich bázi

1997
- 1997-04-15 SE SE9701398A patent/SE9701398D0/xx unknown
1998
- 1998-04-07 HU HU0002104A patent/HUP0002104A3/hu unknown
- 1998-04-07 ID IDW991207A patent/ID22746A/id unknown
- 1998-04-07 CN CN98806075A patent/CN1259951A/zh active Pending
- 1998-04-07 AU AU70909/98A patent/AU733066B2/en not_active Ceased
- 1998-04-07 WO PCT/SE1998/000640 patent/WO1998046606A1/en not_active Ceased
- 1998-04-07 BR BR9808540-9A patent/BR9808540A/pt not_active IP Right Cessation
- 1998-04-07 AT AT98917859T patent/ATE245648T1/de not_active IP Right Cessation
- 1998-04-07 DE DE69816608T patent/DE69816608T2/de not_active Expired - Fee Related
- 1998-04-07 CA CA002286078A patent/CA2286078A1/en not_active Abandoned
- 1998-04-07 KR KR1019997009435A patent/KR20010006350A/ko not_active Withdrawn
- 1998-04-07 IL IL13215398A patent/IL132153A0/xx unknown
- 1998-04-07 EP EP98917859A patent/EP0975636B1/en not_active Expired - Lifetime
- 1998-04-07 SK SK1356-99A patent/SK135699A3/sk unknown
- 1998-04-07 TR TR1999/02538T patent/TR199902538T2/xx unknown
- 1998-04-07 EE EEP199900465A patent/EE9900465A/xx unknown
- 1998-04-07 PL PL98336230A patent/PL336230A1/xx unknown
- 1998-04-07 JP JP54380398A patent/JP2001520645A/ja not_active Ceased
- 1998-08-07 US US09/068,304 patent/US6028074A/en not_active Expired - Fee Related
1999
- 1999-09-27 IS IS5198A patent/IS5198A/is unknown
- 1999-10-14 NO NO995006A patent/NO995006D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
SE9701398D0 (sv)	1997-04-15
SK135699A3 (en)	2000-05-16
AU733066B2 (en)	2001-05-03
NO995006L (no)	1999-10-14
ATE245648T1 (de)	2003-08-15
EP0975636B1 (en)	2003-07-23
EP0975636A1 (en)	2000-02-02
DE69816608T2 (de)	2004-04-15
WO1998046606A1 (en)	1998-10-22
CN1259951A (zh)	2000-07-12
IL132153A0 (en)	2001-03-19
HUP0002104A3 (en)	2002-03-28
US6028074A (en)	2000-02-22
TR199902538T2 (xx)	2000-02-21
HUP0002104A2 (hu)	2001-01-29
JP2001520645A (ja)	2001-10-30
DE69816608D1 (de)	2003-08-28
CA2286078A1 (en)	1998-10-22
BR9808540A (pt)	2000-05-23
NO995006D0 (no)	1999-10-14
KR20010006350A (ko)	2001-01-26
AU7090998A (en)	1998-11-11
PL336230A1 (en)	2000-06-19
EE9900465A (et)	2000-04-17
IS5198A (is)	1999-09-27

Publication	Publication Date	Title
ID22746A (id)	1999-12-09	Senyawa-senyawa baru
ID25628A (id)	2000-10-19	Senyawa-senyawa baru
ID28432A (id)	2001-05-24	Senyawa-senyawa baru
EE9900315A (et)	2000-02-15	Pürrolo[3,4-d]pürimidinooni derivaadid ja nende kasutamine ravimitena
DE69736441D1 (de)	2006-09-14	Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
HUT75776A (en)	1997-05-28	Pyrazolo and pyrrolopyridines, their using, pharmaceutical compositions containing them and intermediates
MXPA04003668A (es)	2004-07-22	Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
IT1265101B1 (it)	1996-10-30	Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
HUP0002346A1 (hu)	2001-05-28	Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény
DE69911785D1 (de)	2003-11-06	Triazolo[4,5-d]pyrimidin-verbindungen
MX9604762A (es)	1997-04-30	Nuevas sulfonamidas y procedimiento para su preparacion.
AU3862997A (en)	1998-02-20	Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
DE69804766D1 (de)	2002-05-16	Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
AU7436098A (en)	1998-11-13	Use of mizolastine for preparing a medicine for treating inflammation